Calcitonin: The Calcium-Lowering Hormone and Its Narrowing Clinical Role

Calcitonin is often taught as the mirror image of parathyroid hormone: where PTH raises blood calcium, calcitonin lowers it. That symmetry is real, but the clinical story is more nuanced — calcitonin turns out to be a minor player in human calcium physiology, even as its salmon version remains a genuinely useful drug in a few specific situations.

What calcitonin is

Calcitonin is a 32-amino-acid peptide hormone produced by the parafollicular C-cells of the thyroid gland (distinct from the follicular cells that make thyroid hormone). It is released when blood calcium rises, and its central action is to bring calcium back down.

How it lowers calcium

Calcitonin works chiefly on osteoclasts, the cells that dissolve bone and release its stored calcium into the blood. Unlike parathyroid hormone — whose bone effects are indirect — calcitonin acts directly on osteoclasts, which carry abundant calcitonin receptors (CTR). Binding the receptor rapidly inhibits osteoclast activity and mobility, essentially quieting the cells that would otherwise pour calcium into the circulation.

It also acts on the kidney to increase urinary calcium excretion. The combined effect — less calcium released from bone, more excreted by the kidney — lowers serum calcium and reduces bone turnover.

Why humans rely on it so little

Here is the twist: despite its neat opposition to PTH, calcitonin plays a surprisingly small role in everyday human calcium balance. People who lose calcitonin (for example after total thyroid removal) do not develop a calcium disorder, and people with very high calcitonin (from a C-cell tumor) do not become dangerously low in calcium. The PTH–vitamin D system dominates human calcium homeostasis; calcitonin is more of a fine-tuning and short-term modulator.

This is partly why calcitonin found its clinical uses not in correcting deficiency, but in situations where its anti-resorptive action can be borrowed as a drug.

Why the drug is the salmon version

Native human calcitonin is weak and short-lived at the human receptor. Salmon calcitonin binds the human calcitonin receptor far more tightly and is degraded more slowly, making it many times more potent for medical use. Synthetic salmon calcitonin is the form used in medicines such as nasal sprays and injections — see calcitonin (salmon).

Its clinical roles — and why they narrowed

Salmon calcitonin has three classic uses:

• Hypercalcemia: injectable calcitonin lowers dangerously high calcium quickly (within hours), useful as a short bridge while stronger, slower drugs take over.
• Paget's disease of bone: it suppresses the overactive bone turnover, though it has been largely displaced by more potent bisphosphonates.
• Osteoporosis: the nasal spray modestly reduces vertebral fracture risk, and calcitonin has a genuine short-term analgesic effect on the pain of acute vertebral fractures.

Two features limit it. First, tachyphylaxis: with continued exposure, osteoclast receptors downregulate and the calcium-lowering effect fades within a day or two — which is why it is a bridge, not a mainstay. Second, pooled analyses of long-term use raised a small possible signal for increased cancer risk, prompting regulators to restrict chronic use. Newer, stronger antiresorptives (bisphosphonates, denosumab) and anabolic agents (teriparatide) have taken over most of calcitonin's former territory.

Calcitonin gene-related peptide: a different molecule

The calcitonin gene also produces, by alternative splicing, an entirely different peptide — calcitonin gene-related peptide (CGRP) — which is central to migraine biology, not calcium balance. It is worth flagging because the shared name causes confusion: CGRP-targeting drugs treat migraine and have nothing to do with calcitonin's bone and calcium actions.

Key takeaways

• Calcitonin is a C-cell hormone that lowers blood calcium by directly inhibiting osteoclasts and increasing renal calcium excretion.
• It acts directly on osteoclasts (which carry calcitonin receptors), unlike PTH, whose bone effects are indirect.
• Despite opposing PTH, calcitonin is a minor player in human calcium homeostasis, which is dominated by PTH and vitamin D.
• Salmon calcitonin is used medically because it is far more potent than the human form; its roles in hypercalcemia, Paget's disease, and osteoporosis have narrowed due to tachyphylaxis and safety concerns.
• CGRP, from the same gene, is a distinct migraine-related peptide unrelated to calcium.

This article is educational and does not constitute medical advice. Calcium disorders and bone disease are diagnosed and managed by clinicians.